Antenatal ultrasound features of isolated recurrent copy number variation in 7q11.23 (Williams syndrome and 7q11.23 duplication syndrome).


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
06 2023
Historique:
revised: 28 02 2023
received: 14 12 2022
accepted: 06 03 2023
medline: 12 6 2023
pubmed: 15 3 2023
entrez: 14 3 2023
Statut: ppublish

Résumé

We aimed to gather fetal cases carrying a 7q11.23 copy number variation (CNV) and collect precise clinical data to broaden knowledge of antenatal features in these syndromes. We retrospectively recruited unrelated cases with 7q11.23 deletion, known as Williams-Beuren syndrome (WBS), or 7q11.23 duplication who had prenatal ultrasound findings. We collected laboratory and clinical data, fetal ultrasound, cardiac ultrasound and fetal autopsy reports from 18 prenatal diagnostic centers throughout France. 40 fetuses with WBS were collected and the most common features were intra-uterine growth retardation (IUGR) (70.0%, 28/40), cardiovascular defects (30.0%, 12/40), polyhydramnios (17.5%, 7/40) and protruding tongue (15.0%, 6/40). Fetal autopsy reports were available for 11 cases and were compared with ultrasound prenatal features. Four cases of fetuses with 7q11.23 microduplication were collected and prenatal ultrasound signs were variable and often isolated. This work strengthens the fact that 7q11.23 CNVs are associated with a broad spectrum of antenatal presentations. IUGR and cardiovascular defects were the most frequent ultrasound signs. By reporting the biggest series of antenatal WBS, we aim to better delineate distinctive signs in fetuses with 7q11.23 CNVs.

Identifiants

pubmed: 36914926
doi: 10.1002/pd.6340
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

734-745

Informations de copyright

© 2023 John Wiley & Sons Ltd.

Références

Ferrero GB, Biamino E, Sorasio L, et al. Presenting phenotype and clinical evaluation in a cohort of 22 Williams-Beuren syndrome patients. Eur J Med Genet. 2007;50(5):327-337. https://doi.org/10.1016/j.ejmg.2007.05.005
Bayés M, Magano LF, Rivera N, Flores R, A. Perez Jurado L. Mutational mechanisms of Williams-Beuren syndrome deletions. Am J Hum Genet. 2003;73(1):131-151. https://doi.org/10.1086/376565
Palacios-Verdú MG, Segura-Puimedon M, Borralleras C, et al. Metabolic abnormalities in Williams-Beuren syndrome. J Med Genet. 2015;52(4):248-255. https://doi.org/10.1136/jmedgenet-2014-102713
Yuan M, Deng L, Yang Y, Sun L. Intrauterine phenotype features of fetuses with Williams-Beuren syndrome and literature review. Ann Hum Genet. 2020;84(2):169-176. https://doi.org/10.1111/ahg.12360
Dang Y, Wan S, Zheng Y, et al. The prenatal diagnosis of seven fetuses with 7q11.23 microdeletion or microduplication. Fetal Pediatr Pathol. 2019;39(4):1-8. https://doi.org/10.1080/15513815.2019.1651802
Kontos H, Manolakos E, Malligiannis P, et al. Prenatal diagnosis of a fetus with 7q11.23 deletion detected by multiplex ligation-dependent probe amplification (MLPA) screening. Prenat Diagn. 2008;28(6):556-558. https://doi.org/10.1002/pd.2020
Krzeminska D, Steinfeld C, Cloez JL, et al. Prenatal diagnosis of Williams syndrome based on ultrasound signs. Prenat Diagn. 2009;29(7):710-712. https://doi.org/10.1002/pd.2263
Marcato L, Turolla L, Pompilii E, et al. Prenatal phenotype of Williams-Beuren syndrome and of the reciprocal duplication syndrome. Clin Case Rep. 2014;2(2):25-32. https://doi.org/10.1002/ccr3.48
Popowski T, Vialard F, Leroy B, Bault JP, Molina-Gomes D. Williams-Beuren syndrome: the prenatal phenotype. Am J Obstet Gynecol. 2011;205(6):e6-e8. https://doi.org/10.1016/j.ajog.2011.09.017
Kobalka AJ, Mrak RE, Gunning WT. A case report of in utero Williams syndrome arterial malformation. Fetal Pediatr Pathol. 2017;36(6):452-456. https://doi.org/10.1080/15513815.2017.1379040
Huang R, Zhou H, Fu F, et al. Prenatal diagnosis of Williams-Beuren syndrome by ultrasound and chromosomal microarray analysis. Mol Cytogenet. 2022;15(1):27. https://doi.org/10.1186/s13039-022-00604-2
Srinivasan S, Howley LW, Cuneo BF, Chatfield KC. In-utero idiopathic ductal constriction: a prenatal manifestation of Alagille and Williams syndrome arteriopathy. J Perinatol. 2018;38(11):1453-1456. https://doi.org/10.1038/s41372-018-0221-9
Collins RT, Kaplan P, Somes GW, et al. Cardiovascular abnormalities, interventions, and long-term outcomes in infantile Williams syndrome. J Pediatr. 2010;156(2):253-258.e1. https://doi.org/10.1016/j.jpeds.2009.08.042
De Rubens Figueroa J, Rodríguez LMO, Hach JLP, et al. Cardiovascular spectrum in Williams-Beuren syndrome. Tex Heart Inst J. 2008;35(3):279-285.
Pasqua AD, Rinelli G, Toscano A, et al. New findings concerning cardiovascular manifestations emerging from long-term follow-up of 150 patients with the Williams-Beuren-Beuren syndrome. Cardiol Young. 2009;19(6):563-567. https://doi.org/10.1017/s1047951109990837
Honjo RS, Monteleone VF, Aiello VD, et al. Cardiovascular findings in Williams-Beuren syndrome: experience of a single center with 127 cases. Am J Med Genet. 2022;188(2):676-682. https://doi.org/10.1002/ajmg.a.62542
Li DY, Brooke B, Davis EC, et al. Elastin is an essential determinant of arterial morphogenesis. Nature. 1998;393(6682):276-280. https://doi.org/10.1038/30522
Metcalfe K, Rucka AK, Smoot L, et al. Elastin: mutational spectrum in supravalvular aortic stenosis. Eur J Hum Genet. 2000;8(12):955-963. https://doi.org/10.1038/sj.ejhg.5200564
Min S, Kinnear C, D’Alessandro LCA, et al. Genetic diagnosis and the severity of cardiovascular phenotype in patients with elastin arteriopathy [Internet]. Circ Genomic Precis Med. 2020;13(6). [cited 2022 Jun 2]. https://www.ahajournals.org/doi/10.1161/CIRCGEN.120.002971
Morris CA, Mervis CB, Paciorkowski AP, et al. 7q11.23 Duplication syndrome: physical characteristics and natural history. Am J Med Genet. 2015;167(12):2916-2935. https://doi.org/10.1002/ajmg.a.37340
Vayssière C, Sentilhes L, Ego A, et al. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol. 2015;193:10-18. https://doi.org/10.1016/j.ejogrb.2015.06.021
Brun S, Pennamen P, Mattuizzi A, et al. Interest of chromosomal microarray analysis in the prenatal diagnosis of fetal intrauterine growth restriction. Prenat Diagn. 2018;38(13):1111-1119. https://doi.org/10.1002/pd.5372
Monier I, Receveur A, Houfflin-Debarge V, et al. Should prenatal chromosomal microarray analysis be offered for isolated fetal growth restriction? A French multicenter study. Am J Obstet Gynecol. 2021;225(6):676.e1-676.e15. https://doi.org/10.1016/j.ajog.2021.05.035
Achiron R, Ben Arie A, Gabbay U, Mashiach S, Rotstein Z, Lipitz S. Development of the fetal tongue between 14 and 26 weeks of gestation: in utero ultrasonographic measurements: in utero tounge measurements. Ultrasound Obstet Gynecol. 1997;9(1):39-41. https://doi.org/10.1046/j.1469-0705.1997.09010039.x
Vanakker O, Vilain C, Janssens K, et al. Implementation of genomic arrays in prenatal diagnosis: the Belgian approach to meet the challenges. Eur J Med Genet. 2014;57(4):151-156. https://doi.org/10.1016/j.ejmg.2014.02.002
Urbán Z, Riazi S, Seidl TL, et al. Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome. Am J Hum Genet. 2002;71(1):30-44. https://doi.org/10.1086/341035
Jiao Y, Li G, Korneva A, et al. Deficient circumferential growth is the primary determinant of aortic obstruction attributable to partial elastin deficiency. Arterioscler Thromb Vasc Biol. 2017;37(5):930-941. https://doi.org/10.1161/atvbaha.117.309079
Rudolph AM. Fetal and neonatal pulmonary circulation. Annu Rev Physiol. 1979;41(1):383-395. https://doi.org/10.1146/annurev.ph.41.030179.002123
Crockett SL, Berger CD, Shelton EL, Reese J. Molecular and mechanical factors contributing to ductus arteriosus patency and closure. Congenit Heart Dis. 2019;14(1):15-20. https://doi.org/10.1111/chd.12714
Battistoni G, Montironi R, Di Giuseppe J, et al. Foetal ductus arteriosus constriction unrelated to non-steroidal anti-Inflammatory drugs: a case report and literature review. Ann Med. 2021;53(1):860-873. https://doi.org/10.1080/07853890.2021.1921253
Parrott A, James J, Goldenberg P, et al. Aortopathy in the 7q11.23 microduplication syndrome. Am J Med Genet. 2015;167(2):363-370. https://doi.org/10.1002/ajmg.a.36859
Van der Aa N, Rooms L, Vandeweyer G, et al. Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome. Eur J Med Genet. 2009;52(2-3):94-100. https://doi.org/10.1016/j.ejmg.2009.02.006

Auteurs

Cécile Courdier (C)

Service de Génétique médicale, CHU Bordeaux, Bordeaux, France.

John Boudjarane (J)

Laboratoire de Cytogénétique, Département de Génétique Médicale, Hôpital Timone Enfants, AP-HM, Marseille, France.

Valérie Malan (V)

Service de Médecine Génomique des Maladies Rares, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.

Christine Muti (C)

Unité de Génétique, Centre hospitalier de Versailles, Versailles, France.

Brian Sperelakis-Beedham (B)

Unité de Génétique, Centre hospitalier de Versailles, Versailles, France.

Sylvie Odent (S)

Service de Génétique clinique, CHU de Rennes, Rennes, France.

Sylvie Jaillard (S)

Service de Cytogénétique et Biologie Cellulaire, CHU de Rennes, Rennes, France.

Chloé Quelin (C)

Service de Génétique clinique, CHU de Rennes, Rennes, France.

Cédric Le Caignec (C)

Service de Génétique médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France.

Olivier Patat (O)

Service de Génétique médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France.

Charlotte Dubucs (C)

Service de Génétique médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France.

Sophie Julia (S)

Service de Génétique médicale, Hôpital Purpan, CHU de Toulouse, Toulouse, France.

Caroline Schluth-Bolard (C)

Service de Génétique, Laboratoire de Cytogénétique Constitutionnelle, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Bron, France.
Laboratoire de Diagnostic Génétique, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.

Carole Goumy (C)

Service de Cytogénétique Médicale, CHU d'Estaing, Clermont-Ferrand, France.

Sylvia Redon (S)

Laboratoire de Génétique Moléculaire et d'histocompatibilité, INSERM U1078, CHRU Morvan, Brest, France.

Jean-Baptiste Gaillard (JB)

Unité de Génétique chromosomique, CHU de Montpellier, Montpellier, France.

Minh Tuan Huynh (MT)

Laboratoire de Génétique médicale, CHU de Nantes, Nantes, France.

Céline Dupont (C)

Unité fonctionnelle de Cytogénétique, Département de Génétique, Hôpital Robert Debré, AP-HP, Paris, France.

Anne-Claude Tabet (AC)

Unité fonctionnelle de Cytogénétique, Département de Génétique, Hôpital Robert Debré, AP-HP, Paris, France.

Guillaume Cogan (G)

Unité fonctionnelle de Cytogénétique, Département de Génétique, Hôpital Robert Debré, AP-HP, Paris, France.

François Vialard (F)

Département de Génétique, Laboratoire de Biologie médicale, CHI de Poissy/Saint-Germain-en-Laye, Poissy, France.

Rodolphe Dard (R)

Département de Génétique, Laboratoire de Biologie médicale, CHI de Poissy/Saint-Germain-en-Laye, Poissy, France.

Guillaume Jedraszak (G)

Laboratoire de Génétique Constitutionnelle, CHU d'Amiens, Amiens, France.
HEMATIM UR4666, Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France.

Florence Jobic (F)

Service de Génétique Clinique et Oncogénétique, CHU d'Amiens, Amiens, France.

Mathilde Lefebvre (M)

Service de Foetopathologie, Hôpital Armand Trousseau, Paris, France.

Geneviève Quenum (G)

Laboratoire de cytogénétique, Hôpital Armand Trousseau, Paris, France.

Saori Inai (S)

Service de Gynécologie, CH de Libourne, Libourne, France.

Mélanie Rama (M)

Institut de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU Lille, Lille, France.

Fanny Sauvestre (F)

Unité de Fœtopathologie, Service de Pathologie, CHU de Bordeaux, Bordeaux, France.

Frédéric Coatleven (F)

Service de Gynécologie Obstétrique, CHU de Bordeaux, Bordeaux, France.

Julie Thomas (J)

Service des maladies Cardio-vasculaires congénitales, Hôpital Haut Lévêque, Bordeaux, France.

Caroline Rooryck (C)

Service de Génétique médicale, CHU Bordeaux, Bordeaux, France.
Univ. Bordeaux, Maladies Rares: Génétique et Métabolisme (MRGM), INSERM U1211, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH